Janus Henderson Investors US’s Novo Nordisk NVO Stock Holding History

Janus Henderson Investors US’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$6.88M	Buy	401,564 +35,302	+10%	+$615K	0.01%	760
2016 Q4	$6.57M	Sell	366,262 -36,726	-9%	-$666K	0.01%	792
2016 Q3	$8.38M	Sell	402,988 -60,216	-13%	-$1.49M	0.01%	730
2016 Q2	$12.5M	Buy	463,204 +41,918	+10%	+$1.15M	0.01%	632
2016 Q1	$11.4M	Sell	421,286 -29,956	-7%	-$803K	0.01%	647
2015 Q4	$13.1M	Sell	451,242 -100,452	-18%	-$2.78M	0.01%	668
2015 Q3	$15M	Buy	551,694 +161,030	+41%	+$4.56M	0.01%	648
2015 Q2	$10.7M	Buy	390,664 +172,656	+79%	+$4.85M	0.01%	698
2015 Q1	$5.82M	Buy	218,008 +183,308	+528%	+$4.22M	﹤0.01%	773
2014 Q4	$734K	Buy	+34,700	New	+$775K	﹤0.01%	993

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Janus Henderson Investors US's NVO Position: Q1 2017 in Review

Janus Henderson Investors US increased its Novo Nordisk (NVO) stake by 9.6% in Q1 2017, buying an estimated $615K and bringing the position to 401,564 shares worth $6.88M. The position accounts for 0.01% of the portfolio, ranked #760.

Janus Henderson Investors US first reported a position in NVO in Q4 2014 and has held it in 10 quarters since. The position peaked at $15M in Q3 2015. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

Janus Henderson Investors US held 401,564 shares of Novo Nordisk worth $6.88M as of Q1 2017.
Janus Henderson Investors US bought 35,302 Novo Nordisk shares in Q1 2017, an estimated $615K.
Novo Nordisk made up 0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #760 holding.
Janus Henderson Investors US first reported a position in Novo Nordisk in Q4 2014 and has held it in 10 quarters since.
Janus Henderson Investors US's Novo Nordisk position peaked at $15M in Q3 2015.
463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.